期刊
NEUROBIOLOGY OF AGING
卷 105, 期 -, 页码 57-63出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2021.04.009
关键词
Blood pressure variability; Cerebral perfusion; Alzheimer's disease; Aging
资金
- NIH/NIA [R01AG064228, R01AG060049, R21AG055034, P50 AG005142, P01 AG052350]
- NSF [DGE1418060]
- Alzheimer's Associa-tion grant [AARG-17-532905]
- Alzheimer's Disease Neuroimaging Ini-tiative (ADNI) (National Institutes of Health) [U01 AG024904]
- DOD ADNI (Department of Defense) [W81XWH1220012]
- National Institute on Aging
- National Institute of Biomedical Imaging and Bioengineering
- Alzheimer's Association
- Alzheimer's Drug Discovery Foundation
- Araclon Biotech
- Biogen
- Bristol-Myers Squibb Company
- CereSpir, Inc.
- Cogstate
- Elan Pharmaceuticals, Inc.
- Eli Lilly and Company
- EuroImmun
- F. Hoffmann-La Roche Ltd
- Fujirebio
- Johnson & Johnson Pharmaceutical Research & Development LLC.
- Merck Co., Inc.
- Meso Scale Diagnostics
- NeuroRx Research
- Novartis Pharmaceuticals Corporation
- Pfizer Inc.
- Piramal Imaging
- Takeda Pharmaceutical Company
- Canadian Institutes of Health Research
- ADNI clinical sites in Canada
- Northern California Institute for Research and Education
- Laboratory for Neuro Imaging at the University of Southern California
- U.S. Department of Defense (DOD) [W81XWH1220012] Funding Source: U.S. Department of Defense (DOD)
Research shows that increased blood pressure variability in older adults is associated with a decline in regional cerebral perfusion, potentially serving as an early marker of vascular dysfunction in aging.
Blood pressure variability (BPV) is linked to dementia risk, possibly through cerebral hypoperfusion. We investigated BPV over 1 year and concurrent regional cerebral perfusion decline in older adults without dementia. Participants underwent 4 blood pressure measurements across 12 months, ASL-MRI at baseline and 12-months, and baseline FDG-PET. Regional perfusion was normalized to precentral gyrus. A subset had cerebral spinal fluid Alzheimer's disease biomarker abnormalities. For every SD increase in BPV, per -fusion decreased in medial orbitofrontal cortex (ss =-.36; p = 0.008), hippocampus (ss =-.37; p = 0.005), entorhinal cortex (ss =-.48; p < 0.001), precuneus (ss =-.31; p = 0.02), inferior parietal cortex (ss =-.44; p < 0.001), and inferior temporal cortex (ss =-.46; p < 0.001). Similar patterns emerged in subsets with biomarker abnormalities. Older adults with elevated BPV exhibit concurrent regional perfusion decline in areas vulnerable to Alzheimer's disease, independent of cerebral hypometabolism. BPV may be an early marker of vascular dysfunction in aging. (c) 2021 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据